Kizuku Yamashita
Overview
Explore the profile of Kizuku Yamashita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawasumi R, Kawamura T, Yamashita K, Tominaga Y, Harada A, Ito E, et al.
Regen Ther
. 2025 Jan;
28():253-261.
PMID: 39834593
Introduction: Systemic administration of induced pluripotent stem cell-derived mesenchymal stem cells (iPS-MSCs) has a therapeutic effect on myocardial ischemia. However, the therapeutic mechanism underlying systemic iPS-MSC-based therapy for ischemic cardiomyopathy...
2.
Matsuhiro Y, Mizote I, Nakamura D, Dohi T, Maeda K, Shimamura K, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
PMID: 39831761
Background: The long-term valve durability of supra-annular self-expanding valves (SEV) and intra-annular balloon-expandable valves (BEV) in patients with small aortic annuli remains unexplored. Aims: This study aimed to determine the...
3.
Matsumoto R, Shimamura K, Shijo T, Maeda K, Yamashita K, Ide T, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
1(4):619-622.
PMID: 39790679
Aortoesophageal fistula is a challenging condition, especially when the aortic arch is involved. Optimal treatment, including surgical approach and adjunctive procedures for organ protection, remains debatable. We describe our strategy...
4.
Kawamura A, Shimamura K, Yoshioka D, Misumi Y, Yamashita K, Maeda K, et al.
JTCVS Tech
. 2024 Oct;
27:51-59.
PMID: 39478919
Background: When transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) is considered as a secondary interventional option, it is desirable to estimate the risk of coronary obstruction during future TAV-in-SAV before the...
5.
Maeda K, Shimamura K, Mizote I, Nakamura D, Yamashita K, Kawamura A, et al.
Gen Thorac Cardiovasc Surg
. 2024 Oct;
PMID: 39441472
Objective: Transapical-transcatheter aortic valve replacement is one of the main interventions indicated for patients where access via peripheral vessels is challenging. However, there have been no reports on the long-term...
6.
Sakakibara S, Shimamura K, Shijo T, Maeda K, Yamashita K, Matsumoto R, et al.
Ann Vasc Surg
. 2024 Oct;
110(Pt B):17-22.
PMID: 39427982
Background: Kommerell's diverticulum (KD) is associated with a high incidence of right-sided aortic arch (RAA). Hybrid thoracic endovascular aortic repair (TEVAR) is an effective and less invasive alternative to open...
7.
Handa K, Maeda K, Pak K, Shimamura K, Yamashita K, Kawamura A, et al.
Ann Thorac Cardiovasc Surg
. 2024 Sep;
30(1).
PMID: 39322554
Purpose: This study aimed to compare the clinical outcomes of isolated surgical aortic valve replacement (SAVR) and transfemoral (TF)-transcatheter aortic valve replacement (TAVR) in low-risk aortic stenosis (AS) patients. Methods:...
8.
A risk model of mortality rate in dialysis patients following transcatheter aortic valve replacement
Yamashita K, Maeda K, Pak K, Shimamura K, Kawamura A, Mizote I, et al.
J Cardiol
. 2024 Aug;
PMID: 39097143
Background: Dialysis patients undergoing transcatheter aortic valve replacement (TAVR) generally have poor prognosis compared with non-dialysis patients. Furthermore, there are few reliable risk models in this clinical setting. Therefore, we...
9.
Mizote I, Nakamura D, Maeda K, Dohi T, Shimamura K, Kawamura A, et al.
Circ J
. 2024 May;
88(12):1937-1945.
PMID: 38735703
Background: Based on the results of a clinical trial in Japan, transcatheter aortic valve replacement (TAVR) for hemodialysis (HD) patients gained approval; however, mid-term TAVR outcomes and transcatheter aortic valve...
10.
Yamashita K, Shimamura K, Maeda K, Kawamura A, Taira M, Yoshioka D, et al.
JTCVS Tech
. 2023 Dec;
22:169-177.
PMID: 38152205
Objective: Whereas transcatheter aortic valve replacement is widely implemented, annular rupture is a devastating complication and could be highly mortal. However, owing to its rare incidence, the optimal treatment algorithm...